HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Fraser W.H. Sutherland Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sutherland, F. W.H. Search for Related Content PubMed PubMed Citation Articles by Sutherland, F. W.H. Related Collections Valve disease Related Article

---

Original Articles: Adult Cardiac

Invited Commentary

Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Beardmore St, Clydebank, Glasgow, G81 4HX United Kingdom

(Email: fraser.sutherland@gjnh.scot.nhs.uk).

The first 20% of the full text of this article appears below.

It has been 7 years since Cribier [1] performed the first transcatheter aortic valve implantation in a human in 2002, and several more years since the original concept was floated by Andersen [2] in 1992. At the time, CoreValve was acquired by Medtronic Inc (Minneapolis, MN), the company claimed to have achieved in excess of 2,600 implants at 125 centers in 25 countries. Edwards Lifesciences (Irvine, CA) has had similar commercial success with their SAPIEN valve.

The target population for this technology is . . . [Full Text of this Article]

Related Article

Unexpected Complications of Transapical Aortic Valve Implantation

Nawwar Al-Attar, Walid Ghodbane, Dominique Himbert, Céderic Rau, Richard Raffoul, David Messika-Zeitoun, Eric Brochet, Alec Vahanian, and Patrick Nataf
Ann. Thorac. Surg. 2009 88: 90-94. [Abstract] [Full Text] [PDF]